GRAHAM PETER J (EVP General Counsel, Secretary) received a stock award from ANTARES PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/4/2022ACC: 0001016169-22-000031
Officer· EVP General Counsel, Secretary
Since Feb 2019
+12.41K
Net shares
Net buyer
$51.8K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
26.04K acquired · 13.63K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+26.04K
Price / share
—
Trade value
—
% of position
4.3%
3/3/2022
604.20K→630.24K
Common Stock
Direct
Shares
−13.63K
Price / share
$3.80
Trade value
$51.81K
% of position
2.2%
3/3/2022
630.24K→616.61K
Total
Net shares
+12.41K
Net value
-$51.81K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/3/2022 | A · Award | +26.04K | — | — | 4.3% | 604.20K | 630.24K |
| Common Stock Direct | 3/3/2022 | F · Tax Withholding | −13.63K | $3.80 | $51.81K | 2.2% | 630.24K | 616.61K |
| Total | +12.41K | -$51.81K | ||||||
Derivative Transactions0
No derivative transactions reported